For hospitalizations during Omicron, these numbers ranged from 81% within 6 months of the second dose to 57% 6 months after the second dose and 90% from the third dose.
“That’s great news,” said Dr. Manjusha Gagrani, director of the Vaccine and Infectious Diseases Research Center and head of pediatric infectious diseases at Baylor Scott & White Health. The boost is working, she said, and this study really points out the need to do so.